mdr_clinical_evaluation_screener
[MDR Article 61 clinical evaluation report (CER) & equivalence screener. Statutory audit, read-only, side-effect free]. Evaluates clinical evaluation sufficiency under Regulation (EU) 2017/745 Article 61 and Annex XIV, scoring literature search protocols, benefit-risk ratios, PMCF plans, and auditing Article 61(5) competitor access contracts. Usage: Pass clinical evaluation attributes and equivalence claims to audit sufficiency score before Notified Body submission. Returns: JSON object with { deviceName: string, overallSufficiencyScorePercent: number, statutoryVerdict: string, equivalenceAudit: object, literatureProtocolAudit: object, clinicalDataSufficiencyAudit: object, pmcfAudit: object, gapFindings: array, mandatoryNotifiedBodySubmissionItems: array }.
Tool call template
Replace each placeholder with a value matching the input schema. Only required parameters are included; add optional parameters as needed.
{
"id": 1,
"jsonrpc": "2.0",
"method": "tools/call",
"params": {
"arguments": {
"deviceName": "<deviceName>",
"deviceRiskClass": "<deviceRiskClass>",
"isImplantableDevice": "<isImplantableDevice>",
"reliesOnClinicalEquivalenceToPredicate": "<reliesOnClinicalEquivalenceToPredicate>",
"literatureSearchProtocolDefined": "<literatureSearchProtocolDefined>",
"literatureAppraisalCriteriaDocumented": "<literatureAppraisalCriteriaDocumented>",
"ownClinicalInvestigationConducted": "<ownClinicalInvestigationConducted>",
"clinicalSafetyAndPerformanceEndpointsBenchmarked": "<clinicalSafetyAndPerformanceEndpointsBenchmarked>",
"benefitRiskRatioAcceptable": "<benefitRiskRatioAcceptable>",
"pmcfPlanFormulatedAnnexXivPartB": "<pmcfPlanFormulatedAnnexXivPartB>"
},
"name": "mdr_clinical_evaluation_screener"
}
}Input Schema
| Name | Required | Description | Default |
|---|---|---|---|
| deviceName | Yes | Commercial trade name of the medical device under evaluation | |
| deviceRiskClass | Yes | MDR Risk class of the device | |
| isImplantableDevice | Yes | Whether device is implantable (triggers strict Article 61(4) clinical investigation rule) | |
| benefitRiskRatioAcceptable | Yes | Whether clinical evaluation concludes that risks are acceptable compared to clinical benefits | |
| literatureSearchProtocolDefined | Yes | Whether a systematic literature search protocol (PICO, databases, search strings) is documented | |
| pmcfPlanFormulatedAnnexXivPartB | Yes | Whether a proactive Post-Market Clinical Follow-up (PMCF) Plan is established | |
| lastLiteratureSearchCutoffDateIso | No | Date of most recent literature search cutoff (YYYY-MM-DD) | |
| ownClinicalInvestigationConducted | Yes | Whether pre-market clinical investigations were performed with the subject device | |
| predicateDeviceAccessContractSigned | No | Article 61(5): For Class III/implantables, whether a contract with predicate manufacturer granting full technical doc access exists | |
| literatureAppraisalCriteriaDocumented | Yes | Whether weighted data appraisal criteria (methodology, relevance) are specified (MDCG 2020-6) | |
| reliesOnClinicalEquivalenceToPredicate | Yes | Whether clinical evaluation relies on equivalence to a predicate device (Annex XIV 3) | |
| clinicalSafetyAndPerformanceEndpointsBenchmarked | Yes | Whether clinical safety and performance endpoints are quantitatively benchmarked against state of the art |